MARMAR
- Company typePrivate
- Founded2024
- HeadquartersAbuja, Nigeria
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
MARMAR firmographics
Firmographics- Name
- MARMAR
- Legal name
- MARMAR Health, Inc.
- Website
- https://marmar.life
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
MARMAR industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)
- akta.pro secondary industry
- SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE)
Keywords
Where MARMAR is headquartered
LocationHeadquarters
- HQ city
- Abuja
- HQ country
- Nigeria
- HQ region
- Africa
Markets served
MARMAR business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- MARMAR Pro Subscription: Optional paid subscription (MARMAR Pro) offering expanded features beyond the free tier. Subscriptions are billed through Apple App Store or Google Play. Free tier includes limited voice conversation allowance; Pro unlocks or expands these features.
- Free Tier: Freemium model with basic medication tracking, safety analysis, and limited voice conversations. Serves as customer acquisition and conversion funnel for Pro subscription.
- API/SDK Licensing: B2B API access for healthcare technology integrators (EMR/EHR vendors, hospitals, insurers) using tenant-scoped API keys with rate limits. Revenue derived from per-tenant API access.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free tier with basic medication safety features and limited voice conversations |
| Subscription | Monthly | MARMAR Pro subscription unlocking expanded features |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
MARMAR product offering
Product offeringCore offering
MARMAR is an AI-native medication safety and clinical decision support platform that delivers real-time drug interaction analysis, side-effect detection, and risk alerts. It operates through a patient-facing mobile app with the Yasmar AI assistant (voice and text) and a B2B clinical decision support (CDS) API and TypeScript SDK that embed medication intelligence directly into EMR/EHR systems for clinicians.
Product overview
MARMAR is an AI-native medication safety platform consisting of a consumer-facing mobile app with Yasmar AI assistant for patients, a clinical decision support dashboard for healthcare providers, and an API/SDK product for EHR integration. The platform uses continuous surveillance to review patient medication histories and deliver real-time drug interaction alerts, powered by NLP for plain-language explanations and voice interfaces. The CDS API and TypeScript SDK enable EMR/EHR vendors to embed medication intelligence into existing systems via FHIR-native integration.
Differentiator
Problem solved
Functional benefit
Brands
- Yasmar: AI-powered medication safety assistant that provides voice conversations about medications, drug interactions, side effects, and plain-language explanations for patients and caregivers.
Products and services
- MARMAR Mobile App Patient-facing iOS and Android application for medication management. Features include smart medication analysis, personalized insights, secure medication history, Rx safety checks, LLM-powered guidance, RAG-based knowledge retrieval, medication reminders, alerts, and offline access. Targets individuals managing their own medications or caregivers tracking medications for family members.
- Yasmar AI Assistant Voice- and text-enabled AI assistant that explains drug interactions, side effects, side effects, and medication guidance in plain language. Processes voice conversations using ElevenLabs technology and handles text queries about prescriptions, symptoms, and food/nutrition interactions. Available via mobile app and web.
- MARMAR Pro Subscription Premium in-app subscription tier that unlocks expanded voice conversation limits and additional features on top of the free MARMAR mobile app. Billed monthly through Apple App Store or Google Play with auto-renewal.
- MARMAR Provider Portal Clinical decision support dashboard for healthcare providers. Displays patient medication lists, active safety monitoring, and real-time medication alerts, and integrates directly into EMR workflows via the Co-Pilot feature. Designed for doctors, clinicians, and care teams.
- MARMAR CDS API REST API enabling EHR/EMR systems to synchronize patient context, request medication risk assessments, and receive webhook notifications. Supports patient management, medication safety assessments, and FHIR v4 operations. Authentication via Bearer token (tenant-scoped API key) with default rate limit of 100 requests per minute.
- @marmarteam/sdk (TypeScript SDK) Official TypeScript SDK for the MARMAR CDS API. Provides typed helpers for managing patients, creating medication safety assessments, configuring webhooks, and working with FHIR models. Targets healthcare technology integrators embedding medication intelligence into their platforms.
Companies that use MARMAR
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
MARMAR technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability11 records
Feature7 records
MARMAR partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- MicrosoftcoreMicrosoft is listed as a supporter and partner, indicating potential integration or technology collaboration. Microsoft logo appears in 'Supported & In Partnership With' section alongside other technology partners.
- Health UniversecoreHealth Universe is listed as a supporter and partner, suggesting collaboration on healthcare technology integration or AI capabilities.
- ElevenLabscoreElevenLabs provides voice technology for Yasmar AI assistant, enabling voice conversations with the medication safety platform. This is a critical technology partnership for the voice-enabled features.
- ElevenLabscoreVoice technology provider for Yasmar AI assistant voice conversations. Audio is processed through ElevenLabs to enable conversational medication safety interactions.
- Apple App StorecorePrimary distribution channel for consumer iOS app. Apple processes subscription payments and manages app distribution to iOS users.
- Google PlaycorePrimary distribution channel for consumer Android app. Google processes subscription payments and manages app distribution to Android users.
- Cohere For AIminorMARMAR's founder participated in Cohere For AI talk, indicating collaboration on AI development and research. The founder presented at Cohere For AI 2025 event.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
MARMAR competitors and assessment
Company assessmentDirect peers
- First Databank (FDB): The dominant provider of drug-interaction and medication-safety databases used by most US EHRs. Direct competitor to MARMAR's clinical decision support API, with decades of curated drug data and existing hospital contracts.
- DrugBank: Commercial drug knowledge database offering drug-interaction and clinical reference APIs. Directly comparable to MARMAR's medication safety API and similar buyer profile (EHR vendors, hospitals, researchers).
- DoseSpot: e-Prescribing and drug-interaction screening platform integrated into EHRs and telehealth workflows. Comparable target buyer (EHR vendors, telehealth providers) and similar clinical safety feature set.
- Medi-Span (Wolters Kluwer): Drug database and clinical screening solution sold into EHRs and pharmacy systems. Direct overlap with MARMAR's API for drug-interaction and dosing checks.
- Tabula Rasa HealthCare (now CareKinesis): Medication safety and pharmacy risk-management platform focused on reducing adverse drug events, especially in polypharmacy populations. Closely aligned with MARMAR's mission of preventing medication-related hospitalizations.
Emerging players
- Amino Health: Digital health platform offering consumer-facing medication and care navigation tools with payer/provider distribution. Comparable consumer-plus-enterprise go-to-market pattern to MARMAR.
- Health Universe: Healthcare AI collaboration platform and listed MARMAR partner. Comparable early-stage AI-for-healthcare positioning and overlapping use cases in clinical AI tooling.
Broad incumbents
- Elsevier (ClinicalPath / ClinicalKey): Provides clinical decision support and drug reference content at scale into hospital systems. A broader incumbent whose drug reference products overlap with MARMAR's enterprise offering.
- Merative (Micromedex): Provides Micromedex clinical decision support including drug-interaction and medication-safety content to hospitals and health systems. Comparable functionality to MARMAR's enterprise offering.
- Wolters Kluwer (Lexicomp / UpToDate): Provides Lexicomp and UpToDate clinical decision support including drug-interaction checking. A much larger incumbent offering overlapping medication safety capabilities as part of a broader clinical content portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
MARMAR social profiles
Digital presenceMARMAR financial estimates
Financial estimateRevenue estimate
Valuation estimate
MARMAR leadership team
Management profileNumber of profiles
Profiles1 record
MARMAR funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MARMAR M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MARMAR
What does MARMAR do?
MARMAR is an AI-native medication safety and clinical decision support platform that delivers real-time drug interaction analysis, side-effect detection, and risk alerts. It operates through a patient-facing mobile app with the Yasmar AI assistant (voice and text) and a B2B clinical decision support (CDS) API and TypeScript SDK that embed medication intelligence directly into EMR/EHR systems for clinicians.
Is MARMAR a public or private company?
MARMAR is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MARMAR founded?
MARMAR was founded in 2024. It employs 1 to 10 people.
Where is MARMAR based?
MARMAR is headquartered in Abuja, Nigeria, in the Africa region.
How does MARMAR make money?
Three revenue lines are on record. MARMAR Pro Subscription is the primary driver. The others are free Tier and API/SDK Licensing.
Who are MARMAR's main competitors?
Direct peers on record are First Databank (FDB), DrugBank, DoseSpot, Medi-Span (Wolters Kluwer) and Tabula Rasa HealthCare (now CareKinesis). Emerging players are Amino Health and Health Universe. Broad incumbents are Elsevier (ClinicalPath / ClinicalKey), Merative (Micromedex) and Wolters Kluwer (Lexicomp / UpToDate).
Does MARMAR have an API?
Yes. MARMAR offers a public CDS API for EHR/EMR integration. The REST API supports: patient management (create, update, list), medication safety assessments (create, retrieve, update review status), FHIR v4 resource operations (submit bundles, search, retrieve), and webhook notifications for assessment events. Authentication via Bearer token (tenant-scoped API key). Rate limits: 100 requests per minute default. TypeScript SDK (@marmarteam/sdk) available with typed helpers for patient management, assessments, webhooks, and FHIR models. Developer documentation is at docs.cds.marmar.life.
What industry is MARMAR in?
MARMAR's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software, with a secondary code of HLACANAE, SaMD – Monitoring, Triage & Risk Stratification Software. Its NAICS code is 513210 and its SIC code is 7372.